Avecho Biotechnology Ltd
ASX:AVE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Avecho Biotechnology Ltd
ASX:AVE
|
AU |
|
Valuence Merger Corp I
NASDAQ:VMCA
|
US |
|
Selva Gida Sanayi AS
IST:SELVA.E
|
TR |
|
A
|
Advaxis Inc
F:FAD2
|
US |
|
Nandan Denim Ltd
NSE:NDL
|
IN |
|
Barak Valley Cements Ltd
NSE:BVCL
|
IN |
|
Officina Stellare SpA
MIL:OS
|
IT |
|
K
|
Kumho HT Inc
KRX:214330
|
KR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AVE's stock price target?
Not Available
AVE doesn't have any price targets made by Wall Street professionals.
What is Avecho Biotechnology Ltd's Revenue forecast?
Projected CAGR
4%
For the last 14 years the
compound annual growth rate for
Avecho Biotechnology Ltd's revenue is
-6%.
The projected
CAGR
for the next 12 years is
4%.